A. P. Ducruet

发表

REGULATION OF CDC25A IN HUMAN TUMOR CELLS BY CYCLIN-DEPENDENT KINASE 2

A. Ducruet, A. P. Ducruet, 2004 .

Dual Specificity Protein Phosphatase 5

John S. Lazo, J. Lazo, A. Ducruet, 2020, Definitions.

Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease.

P. Wipf, J. Lazo, A. Ducruet, 2005, Annual review of pharmacology and toxicology.

Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25.

P. Wipf, J. Lazo, A. Ducruet, 2001, Journal of medicinal chemistry.

Microtubule Binding and Disruption and Induction of Premature Senescence by Disorazole C1

P. Wipf, J. Lazo, A. Ducruet, 2009, Journal of Pharmacology and Experimental Therapeutics.

Cellular Analysis of Disorazole C1 and Structure–Activity Relationship of Analogs of the Natural Product

P. Wipf, J. Lazo, A. Ducruet, 2006, Chemical biology & drug design.

Spatial Analysis of Key Signaling Proteins by High-content Solid-phase Cytometry in Hep3B Cells Treated with an Inhibitor of Cdc25 Dual-specificity Phosphatases*

J. Lazo, B. Carr, A. Vogt, 2001, The Journal of Biological Chemistry.

Small molecule inhibitors of dual specificity protein phosphatases

P. Wipf, J. Lazo, A. Ducruet, 2000, Oncogene.

Dual-specificity phosphatases as targets for antineoplastic agents

P. Wipf, J. Lazo, A. Ducruet, 2002, Nature Reviews Drug Discovery.

Regulation of Cdc25A Half-life in Interphase by Cyclin-dependent Kinase 2 Activity*

J. Lazo, A. Ducruet, A. P. Ducruet, 2003, Journal of Biological Chemistry.

Identification of new Cdc25 dual specificity phosphatase inhibitors in a targeted small molecule array.

P. Wipf, J. Lazo, F. Yokokawa, 2000, Bioorganic & medicinal chemistry.